These final results, along with a earlier report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the principle of focusing on ACKR3 as a novel strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated Conditions. Based on available https://williamv739nfu4.bcbloggers.com/profile